ÜbersichtsarbeitOpen Access
Multifunctional CD38 in the pathogenesis and treatment of B-cell lymphomas
American Journal of Blood Research · 2026 · 16 (3) · 40-64
DOI: 10.62347/behs5368 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Blood Research, 2026. Verfasst von Katherine J Young. Beteiligte Einrichtung: College of Arts and Sciences, Department of Neuroscience, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
B-cell lymphomaCAR-T immunotherapyCD20-negative large B-cell lymphomasCD38antibodybiomarkerdaratumumabisatuximabprognosistargeted therapy
Autor:innen und Institutionen
- College of Arts and Sciences, Department of Neuroscience, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA.
Zitieren
APA
Young, K. J. (2026). Multifunctional CD38 in the pathogenesis and treatment of B-cell lymphomas. American Journal of Blood Research, 16(3), 40-64. https://doi.org/10.62347/behs5368
Vancouver
Young KJ. Multifunctional CD38 in the pathogenesis and treatment of B-cell lymphomas. American Journal of Blood Research. 2026;16(3):40-64. doi:10.62347/behs5368
BibTeX
@article{Young2026,
author = {Young, Katherine J},
title = {Multifunctional CD38 in the pathogenesis and treatment of B-cell lymphomas},
journal = {American Journal of Blood Research},
year = {2026},
volume = {16},
number = {3},
pages = {40--64},
doi = {10.62347/behs5368}
}
EUVIMED